Multi-frequency impedance monitoring system

• US 8,744,565 B2
• Filed: 04/30/2008
• Issued: 06/03/2014
• Est. Priority Date: 04/30/2008
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Zielinski, Todd M., Hettrick, Douglas A., Sarkar, Shantanu
• Primary Examiner(s): HINDENBURG, MAX F
• Application Number:
  US12/112,765
• Publication Number:
  US 20090275855A1
• Time in Patent Office: 2,225 Days
• Field of Search: 600/300, 600544-548, 600/554, 600/587, 607 1- 3, 607 39- 76
• US Class Current: 600/547
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0538 invasively, e.g. using a catheter
• CPC Class Codes: A61B 5/0809 by impedance pneumography
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: A61B 5/7257 using Fourier transforms
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance

Abstract

A system and method is provided to measure intrathoracic complex impedance and to identify and indicate disease conditions based on the impedance measurements. Multiple impedance vectors may betaken into account, and an optimal vector may be selected to provide the most useful impedance measurement for the identification and indication of disease conditions.

Claims

1. A method of determining and indicating a disease condition, the method comprising:

injecting a first current having a first frequency between a pair of electrodes having a tissue segment therebetween wherein the pair of electrodes is positioned for intrathoracic impedance measurement;

measuring a magnitude and a phase angle of impedance in the tissue segment at the first frequency;

comparing at least one of the measured magnitude of impedance and the measured phase angle of impedance at the first frequency to a reference value of impedance magnitude and a reference value of impedance phase angle, respectively, established at the first frequency;

evaluating at least one of a difference between the measured magnitude of impedance and the reference value of impedance magnitude, and a difference between the measured phase angle of impedance and the reference value of impedance phase angle, to determine whether the tissue segment is in a diseased condition;

providing an indicator of disease based on the determination of whether the tissue is in a diseased condition; and

wherein the first frequency is a low frequency no greater than about 10 kiloHertz, and an indicator of pulmonary edema is provided based on an increase in the measured phase angle of impedance from the reference value of impedance phase angle.

2. A method of determining and indicating a disease condition, the method comprising:

injecting a first current having a first frequency between a pair of electrodes having a tissue segment therebetween wherein the pair of electrodes is positioned for intrathoracic impedance measurement;

measuring a magnitude and a phase angle of impedance in the tissue segment at the first frequency;

comparing at least one of the measured magnitude of impedance and the measured phase angle of impedance at the first frequency to a reference value of impedance magnitude and a reference value of impedance phase angle, respectively, established at the first frequency;

evaluating at least one of a difference between the measured magnitude of impedance and the reference value of impedance magnitude, and a difference between the measured phase angle of impedance and the reference value of impedance phase angle, to determine whether the tissue segment is in a diseased condition;

providing an indicator of disease based on the determination of whether the tissue is in a diseased condition; and

wherein the first frequency is a low frequency no greater than about 10 kiloHertz, and an indicator of pulmonary edema is provided based on both a decrease in the measured magnitude of impedance from the reference value of impedance magnitude, and an increase in the measured phase angle of impedance from the reference value of impedance phase angle.